The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines

BACKGROUND: Venous thromboembolism (VTE) is a common complication among patients with cancer and is one of the most common causes of increased morbidity and mortality. The use of direct oral anticoagulants (DOACs) for thromboprophylaxis and treatment of cancer-associated venous thromboembolism (CA-V...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsubaie, Norah S., Al Rammah, Shahad M., Alshouimi, Reema A., Alzahrani, Mohammed Y., Al Yami, Majed S., Almutairi, Abdulaali R., Alfayez, Osamah M., Korayem, Ghazwa B., Almohammed, Omar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556878/
https://www.ncbi.nlm.nih.gov/pubmed/34717653
http://dx.doi.org/10.1186/s12959-021-00326-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556878/
https://www.ncbi.nlm.nih.gov/pubmed/34717653
http://dx.doi.org/10.1186/s12959-021-00326-2

Ejemplares similares